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Background: Recently developed EPC capturing stent, on which surface is coated with anti CD34 antibody, appears to accelerate tissue formation 
but does not reduce intimal hyperplasia. Since CD34-positive cells to be captured contain various cell types beside EPCs, degree of selective 
capturing of EPCs must be not so high. On the other hand, VEGF receptor is exclusively expressed on endothelial lineage cells. In this study, VEGF-
bound stent was newly devised aiming at highly selective capturing of EPCs, and in vivo performances in early period of stenting were evaluated in 
porcine coronary model in comparison with those of anti CD34 antibody-bound stents.
Methods and Results: Metallic stent were coated with vinyl alcohol copolymer, followed by activation of surface hydroxyl group and subsequent 
protein binding (VEGF-bound stents n=39 and anti porcein CD34 antibody-bound stents n=33) were in-house prepared. At 2, 7, 14 and 42 days after 
stenting, coronary arteries were harvested. At 2 day-stenting of VEGF-bound stent, a low population of KDR -positive cells adhered on stent struts 
were observed. At one to two weeks, stent struts were covered by newly regenerated tissues which were immune-fluorescently positive for CD34 and 
KDR. At 2-week, scanning electron microscopic images showed that uniform monolayerd tissue formed on struts is morphometrically resembled 
to native endothelium and exhibited continuous tissue appearance with native tissues. On the other hand, for anti CD34 antibody-bound stents, 
high population of adhered cells at 2-day stenting and non-uniform multilayered cell aggregates at 1- to 2-week stenting were observed, although 
endothelial-like cell-based tissue was also formed here and there. Neointimal thicknesses at 2-week stenting appeared to be low for both stents 
(67.9±27.3μm vs 79.8±25.2μm). (data on longer period of stenting is acquiring).
Conclusion: VEGF-bound stent provides highly selective capturing of EPC followed by accelerated endothelial tissue formation compared with anti 
CD34 antibody-bound stents. Rapid, high quality and intact endothelium tissue formation provides beneficial therapeutic option for cardiovascular 
stenting.
